Innovations

When few diagnostic tests could identify SARS-CoV-2 infection in the early days of the pandemic, GH Labs and our partners mobilized to bridge gaps.

To help healthcare providers leapfrog barriers in cervical cancer screening and prevention, GH Labs developed a smartphone app that applies machine learning to detect pre-cancerous lesions with high accuracy.

With collaborators at Washington University School of Medicine in St. Louis, GH Labs is developing a simplified, automated, and highly accurate approach for providers to identify and help address risks in childbirth.

With our partners, a cross-programmatic team at GH Labs is developing a novel diagnostic platform with a similar user experience to standard lateral flow assays and a high-volume, low-cost manufacturing product profile.